TARGET-AID Trademark

Trademark Overview


On Friday, March 22, 2024, a trademark application was filed for TARGET-AID with the United States Patent and Trademark Office. The USPTO has given the TARGET-AID trademark a serial number of 98463696. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, April 9, 2025. This trademark is owned by Bio Palette Co., Ltd.. The TARGET-AID trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the field of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; research and development, product development advisory services, and scientific research advisory services relating thereto in the fields of protein, antibody, and microorganism scientific study, and the study of cells; structural and functional analysis of the genome with genome editing technology; DNA screening for scientific research purposes with genome editing technology; research and development, product development advisory services, and scientific research advisory services relating thereto in the field of genome editing technology; scientific research in the field of genetics and genetic engineering with genome editing technology; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs, all with genome edi...
target-aid

General Information


Serial Number98463696
Word MarkTARGET-AID
Filing DateFriday, March 22, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, April 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 29, 2025

Trademark Statements


Goods and ServicesResearch and development in the field of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; research and development, product development advisory services, and scientific research advisory services relating thereto in the fields of protein, antibody, and microorganism scientific study, and the study of cells; structural and functional analysis of the genome with genome editing technology; DNA screening for scientific research purposes with genome editing technology; research and development, product development advisory services, and scientific research advisory services relating thereto in the field of genome editing technology; scientific research in the field of genetics and genetic engineering with genome editing technology; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs, all with genome editing technology; development of pharmaceuticals, cosmetics or foodstuffs, all with genome editing technology; technical advisory services relating to development of pharmaceuticals, cosmetics or foodstuffs, all with genome editing technology; information services, namely, providing information relating to the development of pharmaceuticals, cosmetics or foodstuffs, all with genome editing technology; scientific and technological services, namely, scientific testing, examination or research relating to medical treatment or medical technology with genome editing technology; information services, namely, providing information for scientific testing, examination or research purposes relating to medical treatment or medical technology with genome editing technology; scientific and technological services, namely, scientific testing or research relating to genome or gene to which genome editing technology is applied; scientific and technical research and technological development of bioinformatic tools in the fields of editing, modulation, modification, engineering, regulation, repair and therapy of gene, genome and cells to develop human pharmaceutical, biological preparations, and diagnostic products and services; research and development for the pharmaceutical industry and biotechnology industry with genome editing technology; research and development of biotechnology for others; research and development of genome editing technology for others; development of pharmaceutical preparations and medicines; biotechnology research; research and development in the field of genomics and biotechnology; technical advisory consulting services in the field of genomics and biotechnology; structural and functional analysis of genomes; scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy all to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; scientific study and research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy all to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; scientific and technological services, namely, design of bioinformatic algorithms for use in scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy all to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; testing, examination being inspection or research on agriculture, livestock breeding or fisheries

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 22, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBio Palette Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChiyoda-ku 100-0004
JP

Trademark Events


Event DateEvent Description
Friday, March 22, 2024NEW APPLICATION ENTERED
Tuesday, August 20, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 1, 2024ASSIGNED TO EXAMINER
Friday, October 4, 2024NON-FINAL ACTION WRITTEN
Friday, October 4, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 4, 2024NON-FINAL ACTION E-MAILED
Thursday, December 5, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, March 24, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 24, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 24, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 1, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 5, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED